Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Genetic Mechanisms Driving Uterine Leiomyoma Pathobiology, Epidemiology, and Treatment

Genes(2024)10.3390/genes15050558Source: DataRank Database

Genetic Mechanisms Driving Uterine Leiomyoma Pathobiology, Epidemiology, and Treatment is a research paper published in Genes (2024). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 6.57)OA: goldTopics (59)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Eslam Saad,Irem Kurt ORCID,Mostafa A. Borahay ORCID,Malini Ramaiyer ORCID

Live enrichment

PubMed:38790186 PMC:PMC11121260 OpenAlex:https://openalex.org/W4396545926

National Institutes of Health

Grant: R01HD094380

National Institutes of Health

Grant: R01HD111243

NIH HHS

Grant: R01HD094380, R01HD111243

National Institutes of Health

Grant: 1R01HD111243-01

Role of senescent cells in uterine fibroid pathogenesis

National Institutes of Health

Grant: 5R01HD094380-04

Mechanisms of actions(s) of simvastatin in uterine leiomyoma

FWCI

6.57

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2073-4425/15/5/558/pdf?version=1714209038

publisherhttps://www.mdpi.com/2073-4425/15/5/558/pdf?version=1714209038

publisherhttps://www.mdpi.com/2073-4425/15/5/558/pdf

journalhttps://doi.org/10.3390/genes15050558

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38790186

Fields of Study

Uterine Myomas and TreatmentsEndometriosis Research and TreatmentOvarian cancer diagnosis and treatment0301 basic medicine03 medical and health sciences0303 health sciencesHumansFemaleLeiomyomaUterine NeoplasmsEpigenesis, GeneticDNA MethylationGenome-Wide Association Study

MeSH Terms

FemaleHumansLeiomyomaUterine NeoplasmsDNA MethylationEpigenesis, GeneticGenome-Wide Association Study

Keywords

PathophysiologyEpidemiologyPathogenesismicroRNALeiomyomaChemokineBioinformaticsMedicineUterine leiomyomaPelvic painUterusBiologyPathologyImmunologyGeneInflammationInternal medicineGeneticsSurgeryGene therapyCytogeneticsUterine FibroidsFOS: Computer and information sciencesUterine SarcomasUterine Conditions and TreatmentsReviewEpigenesis, GeneticUterine AnomaliesHealth SciencesHumansClinical Implications of Uterine Anomalies and TreatmentObstetrics and GynecologyDNA MethylationUterine Artery EmbolizationDiagnosis and Management of EndometriosisReproductive MedicineUterine NeoplasmsFemaleGenome-Wide Association Study

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being